COVID-19 Antiviral Treatment Provider Locations

A discontinued dataset listing U.S. locations providing specific COVID-19 therapeutics, including Paxlovid, Lagevrio, and Veklury, as of January 31, 2024. It was sourced from datahub.hhs.gov and includes provider details and inventory levels. The data was actively updated with schema changes through early 2022.

Use Cases

• Map provider locations using Geocoded Address, City, and State Code to analyze geographic treatment access disparities.
• Analyze inventory levels and provider activity over time using Courses Available and Last Report Date columns.
• Identify provider types and statuses for outreach or policy targeting using Provider Name, Provider Status, and NPI fields.
• Filter for specific antiviral drugs like Paxlovid or Lagevrio using the Order Label or National Drug Code columns.

Strengths

• Includes specific drug-level detail for three major COVID-19 antiviral therapeutics.
• Contains geocoded location data for spatial analysis.
• Schema was iteratively updated in early 2022 based on operational needs.

Limitations

• Dataset is deprecated and no longer updated as of January 31, 2024, making it temporally stale.
• Sample data and total row count are unavailable for assessing dataset scale.
• Public contact information is noted as a limitation, potentially affecting data completeness.

Provenance

Source

datahub.hhs.gov

Collection Method

null

Time Range

Coverage up to January 31, 2024, with detailed updates in early 2022.

Freshness

null

Geography

United States, inferred from State Code and County columns.